Clinical Trial

Study of Clinical Features and Efficacy of Small Intestinal Bacterial Overgrowth in Patients With Abdominal Distension

Unknown Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated July 24, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Most studies of bloating have focused on functional factors, while data on organic abdominal distention are rare, and studies that combine small intestine bacterial overgrowth and/or oral cecum transit time abnormalities are more urgent to explore. On this basis, patients with functional abdominal distension complicated with small intestine bacterial overgrowth were divided according to whether there was abnormal oral cecum transit time, and given the same treatment plan. The relief effect of abdominal distension, small intestine bacterial overgrowth turning negative and oral cecum transit time recovery were observed, so as to further clarify the cause of abdominal distension patients.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06518850
Lead Sponsor Peking Union Medical College Hospital
Collaborators: Navy General Hospital, Beijing, Air Force Military Medical University, China, Beijing Tongren Hospital, Beijing Friendship Hospital, Beijing Chao Yang Hospital, Beijing Tiantan Hospital, The Luhe Teaching Hospital of the Capital Medical University, China-Japan Friendship Hospital, Beijing Aerospace General Hospital, Beijing Jishuitan Hospital, Peking University Third Hospital
Conditions Small Intestine Bacterial Overgrowth
Enrollment 30 participants
Start Date 2024-08-01
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-24